Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate pharmacokinetics with novobiocin in rheumatoid arthritis
NL-OMON60858Phase 1Suspended
- Sponsor
- Amplio Pharma
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of methotrexate and novobiocin in rheumatoid arthritis (RA), sponsored by Amplio Pharma. Started Aug 2025; status: suspended.
02
Drugs
methotrexatenovobiocin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON60858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60858.